
Wegovy and NAION: The Ultimate Eye-Opener [2026]
Introduction to the Wegovy and Naion Update Welcome to this autoritative analysis of Wegovy and Naion. As of April 2026, research indicates a, link between semaglutide (Wegovy, Ozempic) and a rare, irreversible vision loss condition known as Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). Regulatory bodies in Europe and the UK have advised updating product labels to list NAION as a




